<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00085722</url>
  </required_header>
  <id_info>
    <org_study_id>H-2004-0112</org_study_id>
    <secondary_id>K23AT001879-01</secondary_id>
    <nct_id>NCT00085722</nct_id>
  </id_info>
  <brief_title>Joint Injections for Osteoarthritic Knee Pain</brief_title>
  <official_title>The Efficacy of Prolotherapy in Osteoarthritic Knee Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether prolotherapy (PrT), a therapy based on
      injection of a sugar solution in and around the knee, can decrease pain and disability from
      knee osteoarthritis (OA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OA is a common, debilitating condition for which there is no cure and no known cause.
      Prolotherapy (PrT) is an injection-based therapy for chronic musculoskeletal pain in which an
      irritant solution is injected at painful ligaments and tendons to produce stronger connective
      tissue and decrease pain. Although limited studies suggest PrT is effective may be effective
      for low back pain, its use has not been rigorously studied in human clinical trials for
      osteoarthritis.

      Participants in this study will be randomly assigned to receive one of three treatments:
      standard PrT, injections with a saline placebo, or a pamphlet with recommendations for home
      knee physical therapy. Injections will be given at Weeks 1, 5, and 9; injection group
      subjects will have the option to receive an additional 2 sets of injections. All participants
      will be assessed for a total of 1 year. A set of disease-specific and general quality-of-life
      questionnaires will be used to assess participants' outcomes . A randomized subset of
      participants (N=38)will receive magnetic resonance imaging (MRI)of the knee at baseline and
      52 weeks. At study completion, participants who did not receive PrT will have the option to
      receive up to five sessions of PrT at no cost. Data will be collected for this group (minus
      MRI) and will be analyzed separately. Enrollment is limited to residents of Southern
      Wisconsin.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2004</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life, pain scores and disability at wks 0, 5, 9, 12, 24, 52</measure>
    <time_frame>Participants will be followed for one year.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcomes include disease and general quality of life indicators (all subjects) and magnetic resonance image (in a subset of 37 subjects).</measure>
    <time_frame>Participants will be monitored for one year.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">111</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Dextrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in Group 1 receive PrT with 15% and 25% dextrose solution, as it is generally practiced in the US today.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in Group 2 will receive the same treatment as Group 1, except that a 0.9% 'normal' saline solution with no known benefit will be used instead of dextrose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At-home physical therapy exercises as a non-injection control</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dextrose Prolotherapy</intervention_name>
    <description>Injection procedure: 50% dextrose is diluted with .9% 'normal' saline and 1% lidocaine to achieve 15% dextrose for ligament injections and 25% dextrose for intra-articular injection.</description>
    <arm_group_label>Dextrose</arm_group_label>
    <other_name>Dextrose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline Prolotherapy</intervention_name>
    <description>7 mL 9% 'normal' saline and 3mL 1% lidocaine</description>
    <arm_group_label>Normal saline</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>At-home physical therapy exercise group</intervention_name>
    <description>Subjects in the at-home physical therapy exercise group will receive a patient information pamphlet about knee osteoarthritis and conservative care instructions for standard at-home physical therapy exercises</description>
    <arm_group_label>Exercise</arm_group_label>
    <other_name>Exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pain from knee osteoarthritis that has impacted life for 3 months to 10 years

          -  X-ray results indicating knee osteoarthritis

        Exclusion Criteria:

          -  Knee osteoarthritis surgical candidate

          -  History of total knee joint repair

          -  Prior use of PrT

          -  Prior fracture of the knee joint

          -  Joint injection of steroids or other drugs within the past 3 months

          -  Rheumatoid or inflammatory arthritis

          -  Chronic use of narcotic medication

          -  Other chronic pain diagnoses

          -  diabetes mellitus

          -  Body mass index (BMI) greater than 45

          -  Unresolved litigation

          -  Pregnancy

          -  Co-morbidity that may interfere with the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David P. Rabago, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin Dept of Family Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northeast Family Medical Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin General Clinical Research Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fammed.wisc.edu/</url>
    <description>University of Wisconsin Department of Family Medicine Web Site</description>
  </link>
  <reference>
    <citation>Rejeski WJ, Ettinger WH Jr, Shumaker S, Heuser MD, James P, Monu J, Burns R. The evaluation of pain in patients with knee osteoarthritis: the knee pain scale. J Rheumatol. 1995 Jun;22(6):1124-9.</citation>
    <PMID>7674241</PMID>
  </reference>
  <reference>
    <citation>Reeves KD, Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med. 2000 Aug;6(4):311-20.</citation>
    <PMID>10976977</PMID>
  </reference>
  <reference>
    <citation>Eberle E, Ottillinger B. Clinically relevant change and clinically relevant difference in knee osteoarthritis. Osteoarthritis Cartilage. 1999 Sep;7(5):502-3.</citation>
    <PMID>10489324</PMID>
  </reference>
  <reference>
    <citation>Klein RG, Eek BC, DeLong WB, Mooney V. A randomized double-blind trial of dextrose-glycerine-phenol injections for chronic, low back pain. J Spinal Disord. 1993 Feb;6(1):23-33.</citation>
    <PMID>8439713</PMID>
  </reference>
  <reference>
    <citation>Ongley MJ, Klein RG, Dorman TA, Eek BC, Hubert LJ. A new approach to the treatment of chronic low back pain. Lancet. 1987 Jul 18;2(8551):143-6.</citation>
    <PMID>2439856</PMID>
  </reference>
  <reference>
    <citation>Dechow E, Davies RK, Carr AJ, Thompson PW. A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford). 1999 Dec;38(12):1255-9.</citation>
    <PMID>10587555</PMID>
  </reference>
  <reference>
    <citation>Yelland MJ, Glasziou PP, Bogduk N, Schluter PJ, McKernon M. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial. Spine (Phila Pa 1976). 2004 Jan 1;29(1):9-16; discussion 16.</citation>
    <PMID>14699269</PMID>
  </reference>
  <reference>
    <citation>Hackett GS, Hemwall GA, Montgomery GA. Ligament and Tendon Relaxation Treated by Prolotherapy. Fifth Ed. ed. Oak Park: Gustav A. Hemwall, 1993</citation>
  </reference>
  <reference>
    <citation>Linetsky FS, FRafael M,. Pain Management, 2002:381-402.</citation>
  </reference>
  <reference>
    <citation>Dorman TA. Prolotherapy: A survey. The Journal of Orthopaedic Medicine 1993;15(2):49-50</citation>
  </reference>
  <reference>
    <citation>Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000 Mar;6(2):68-74, 77-80.</citation>
    <PMID>10710805</PMID>
  </reference>
  <reference>
    <citation>Rogers WH, Wittink H, Wagner A, Cynn D, Carr DB. Assessing individual outcomes during outpatient multidisciplinary chronic pain treatment by means of an augmented SF-36. Pain Med. 2000 Mar;1(1):44-54.</citation>
    <PMID>15101963</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2004</study_first_submitted>
  <study_first_submitted_qc>June 15, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2004</study_first_posted>
  <last_update_submitted>October 9, 2015</last_update_submitted>
  <last_update_submitted_qc>October 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Injection Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

